Clinical Trial Update: Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

View source ↗

Summary

A completed observational study in Japanese patients with Peripheral T-cell Lymphoma who received second-line therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Peripheral T-cell Lymphoma | Status: COMPLETED